110 results on '"Golovko G"'
Search Results
2. LB928 A matched retrospective cohort study assessing the bidirectional association between prurigo nodularis and alopecia areata
- Author
-
Garate, D., Thang, C.J., Lai, J., Hansen, A.C., Golovko, G., Wilkerson, M.G., and Barbieri, J.S.
- Published
- 2024
- Full Text
- View/download PDF
3. LB899 A population-level cohort study evaluating the association between tetracycline-class antibiotic use in acne patients and idiopathic intracranial hypertension risk
- Author
-
Thang, C.J., Garate, D., O'Leary, S., Golovko, G., Wilkerson, M.G., and Barbieri, J.S.
- Published
- 2024
- Full Text
- View/download PDF
4. LB892 Assessing the risk of alopecia areata development in patients with seasonal and food allergies: a matched population-level analysis
- Author
-
Garate, D., Thang, C.J., Murphy, T.L., Sharma, D., Golovko, G., Wilkerson, M.G., Gulati, N., and Ungar, B.
- Published
- 2024
- Full Text
- View/download PDF
5. LB884 A matched retrospective cohort study assessing CGRP inhibition on acne and rosacea development in migraine patients
- Author
-
Thang, C.J., Lai, J., Garate, D., Golovko, G., Wilkerson, M.G., Loder, E., and Barbieri, J.S.
- Published
- 2024
- Full Text
- View/download PDF
6. 121 Atopic dermatitis is associated with an increased risk of central sensitivity disorders: A retrospective cohort analysis
- Author
-
Garate, D., Ravanassa, S., Murphy, T.L., Golovko, G., Hansen, A., and Wilkerson, M.G.
- Published
- 2024
- Full Text
- View/download PDF
7. 109 Prolonged dupilumab use in atopic dermatitis patients is associated with decreased risk of malignancy development
- Author
-
Garate, D., Thang, C.J., Chang, C.T., Owji, S., Murphy, T.L., Golovko, G., Da Rosa, J. Correa, Guttman-Yassky, E., Wilkerson, M.G., and Gulati, N.
- Published
- 2024
- Full Text
- View/download PDF
8. Multifold obtaining of reproductive products of Azov Shemaya Chalcalburnus chalcoides during spawning season
- Author
-
Golovko, G. V., Agapov, S. A., Karpenko, G. I., and Zipelt, L. I.
- Published
- 2013
- Full Text
- View/download PDF
9. EPH249 Development of Substance Use Disorder in Chronic Kidney Disease Patients Experiencing Uremic Pruritus
- Author
-
Garate, D., Thomas, D., Flores, I., Morgan, B., Fu, S., and Golovko, G.
- Published
- 2023
- Full Text
- View/download PDF
10. EPH152 Evaluating Postoperative Complication Risk in Patients with Nicotine Dependence That Undergo Mohs Micrographic Surgery
- Author
-
Garate, D., Thomas, D., Morgan, B., Flores, I., Fu, S., and Golovko, G.
- Published
- 2023
- Full Text
- View/download PDF
11. EPH118 Retrospective Analysis of Acute Complications in Burn Injury Patients with Vitiligo
- Author
-
Garate, D., Thomas, D., Morgan, B., Flores, I., Fu, S., and Golovko, G.
- Published
- 2023
- Full Text
- View/download PDF
12. EPH15 Increased Risk of Adverse Events Following Burn Injury in Patients with Hypothyroidism
- Author
-
Thomas, D., Garate, D., Flores, I., Morgan, B., Fu, S., Golovko, G., El ayadi, A., Song, J., and Wolf, S.E.
- Published
- 2023
- Full Text
- View/download PDF
13. Experimental and theoretical study of the statics of oxygen adsorption by modified type NaA zeolite
- Author
-
Chelyshev, V. Yu., Golovko, G. A., and Fedorov, A. N.
- Published
- 1992
- Full Text
- View/download PDF
14. Reduction of 2-oxa-3,7-diazabicyclo[3.3.0]octanes
- Author
-
Zharkikh, L. N., Muzychenko, G. F., Kul'nevich, V. G., Zavodnik, V. E., Pushkareva, K. S., Golovko, G. V., and Ignatenko, A. V.
- Published
- 1992
- Full Text
- View/download PDF
15. Investigation of modified zeolites for cryogenic removal of oxygen from argon
- Author
-
Fedorov, A. N., Golovko, G. A., and Davydov, I. A.
- Published
- 1990
- Full Text
- View/download PDF
16. Rib for studying adsorbents used for removing oxygen from argon
- Author
-
Fedorov, A. N., Davydov, I. A., and Golovko, G. A.
- Published
- 1990
- Full Text
- View/download PDF
17. Chromatographic analysis of pure cryogenic gases
- Author
-
Bobylev, A. V. and Golovko, G. A.
- Published
- 1987
- Full Text
- View/download PDF
18. DEVELOPMENT OF A PROCEDURE FOR THE EVALUATION OF THE STRESSED-DEFORMED STATE OF PIPE-CONCRETE ELEMENTS THAT ARE STRETCHED OFF-CENTER.
- Author
-
Yermolenko, D., Pents, V., and Golovko, G.
- Subjects
COMPRESSION loads ,DEFORMATIONS (Mechanics) ,CONCRETE - Abstract
Copyright of Eastern-European Journal of Enterprise Technologies is the property of PC TECHNOLOGY CENTER and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2017
- Full Text
- View/download PDF
19. Adsorption of cryogenic gases on activated carbon fibers
- Author
-
Golovko, G. A., Fridman, L. I., Ignatov, Yu. Ya., Chelyshev, V. Yu., Perlin, V. A., Seballo, A. A., and Ermolenko, I. N.
- Published
- 1977
- Full Text
- View/download PDF
20. Region of OH deformation vibrations in micas
- Author
-
Metsik, M. S., Shishelova, T. I., Golovko, G. F., and Epifantseva, Z. N.
- Published
- 1971
- Full Text
- View/download PDF
21. Slim-Filter: an interactive windows-based application for illumina genome analyzer data assessment and manipulation
- Author
-
Golovko Georgiy, Khanipov Kamil, Rojas Mark, Martinez-Alcántara Antonio, Howard Jesse J, Ballesteros Efren, Gupta Sharu, Widger William, and Fofanov Yuriy
- Subjects
Computer applications to medicine. Medical informatics ,R858-859.7 ,Biology (General) ,QH301-705.5 - Abstract
Abstract Background The emergence of Next Generation Sequencing technologies has made it possible for individual investigators to generate gigabases of sequencing data per week. Effective analysis and manipulation of these data is limited due to large file sizes, so even simple tasks such as data filtration and quality assessment have to be performed in several steps. This requires (potentially problematic) interaction between the investigator and a bioinformatics/computational service provider. Furthermore, such services are often performed using specialized computational facilities. Results We present a Windows-based application, Slim-Filter designed to interactively examine the statistical properties of sequencing reads produced by Illumina Genome Analyzer and to perform a broad spectrum of data manipulation tasks including: filtration of low quality and low complexity reads; filtration of reads containing undesired subsequences (such as parts of adapters and PCR primers used during the sample and sequencing libraries preparation steps); excluding duplicated reads (while keeping each read’s copy number information in a specialized data format); and sorting reads by copy numbers allowing for easy access and manual editing of the resulting files. Slim-Filter is organized as a sequence of windows summarizing the statistical properties of the reads. Each data manipulation step has roll-back abilities, allowing for return to previous steps of the data analysis process. Slim-Filter is written in C++ and is compatible with fasta, fastq, and specialized AS file formats presented in this manuscript. Setup files and a user’s manual are available for download at the supplementary web site (https://www.bioinfo.uh.edu/Slim_Filter/). Conclusion The presented Windows-based application has been developed with the goal of providing individual investigators with integrated sequencing reads analysis, curation, and manipulation capabilities.
- Published
- 2012
- Full Text
- View/download PDF
22. ChemInform Abstract: Reduction of 2-Oxa-3,7-diazabicyclo(3.3.0)octanes.
- Author
-
ZHARKIKH, L. N., MUZYCHENKO, G. F., KUL'NEVICH, V. G., ZAVODNIK, V. E., PUSHKAREVA, K. S., GOLOVKO, G. V., and IGNATENKO, A. V.
- Published
- 1993
- Full Text
- View/download PDF
23. Pre-existing skin diseases as predictors of post-burn pruritus.
- Author
-
Obanigba G, Jay JW, Wolf S, Golovko G, Song J, Obi A, Efejuku T, Johnson D, and El Ayadi A
- Subjects
- Humans, Female, Retrospective Studies, Male, Adult, Middle Aged, Skin Diseases etiology, Risk Factors, Aged, Burns complications, Pruritus etiology
- Abstract
Background: Post-burn pruritus (PBP) has been shown to adversely affect burn patients' quality of life. However, the predictors of PBP are not known. We hypothesize a pre-existing pruritic skin diagnosis is associated with an increased risk of adverse outcomes following a burn injury., Methods: This retrospective study utilized data from the TriNetX electronic health record. Burn patients with a history of a pruritic skin disorder were compared to patients without a diagnosed skin disorder and the occurrence of pruritus was compared between the two cohorts., Results: Patients with pre-existing skin conditions were more likely to develop PBP. The risk of PBP was highest 1 year after injury. Stratification by percent TBSA burned, gender, race, and age showed an increased risk of PBP for females, Caucasians, older patients, and those with large burns., Conclusion: A pre-existing pruritic skin diagnosis is highly associated with developing pruritus following a burn injury., Competing Interests: Declaration of competing interest The authors have no conflict to disclose., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
24. Granuloma annulare and the risk of autoimmune conditions: a multicentre retrospective cohort analysis.
- Author
-
Garate D, Thang CJ, Schmidt M, Ravanassa S, Jimenez AR, Ross LS, Golovko G, Barbieri JS, and Wilkerson MG
- Subjects
- Humans, Retrospective Studies, Female, Male, Middle Aged, Adult, Aged, Risk Factors, Young Adult, Adolescent, Granuloma Annulare epidemiology, Granuloma Annulare pathology, Granuloma Annulare immunology, Granuloma Annulare diagnosis, Autoimmune Diseases epidemiology, Autoimmune Diseases immunology
- Abstract
Competing Interests: Conflicts of interest J.S.B. has received consulting fees from Dexcel Pharma for work unrelated to the current study. The other authors declare no conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
25. Elevated Cardiac Troponin I Level Associated to Cardiac Dysfunction in Burned Patients.
- Author
-
Segura C, Golovko G, Obias I, Shah S, El Ayadi A, Wolf S, and Song J
- Subjects
- Humans, Male, Female, Retrospective Studies, Middle Aged, Adult, Myocardial Infarction blood, Sepsis complications, Biomarkers blood, Burns complications, Burns blood, Troponin I blood
- Abstract
Severely burned patients often develop cardiac dysfunction and heart failure. The purpose of this retrospective study is to evaluate the role of cardiac troponin I (cTI) and its association to patients with burns. Patients deidentified data were collected from a national database in May 2023. Adult patients with burns who had cTnI lab counted were enrolled in this study. Patients were grouped by the cTnI mean level within 72 h including patients with elevated cTnI levels at >0.3 ng/mL (n = 2188 patients) and patients with nonelevated cTnI level (<0.04 ng/mL) (n = 3200). The cohorts were further stratified by less than 20% TBSA mild burn population and >20% TBSA severe burn population to replicate the severity of burns. The 30-day incidences of acute myocardial infarction (MI), sepsis, and mortality were investigated after the cohorts were propensity-matching balanced. The odds ratios (ORs) with 95% CI for MI were (9.829/7.081-13.645), sepsis (1.527/1.269-1.959), and mortality (2.586/2.110-3.170), respectively (P < .05). The groups that were further stratified into mild burn and severe burn had the following results: The mild burn ORs and 95% CI for MI was (6.237/3.986-9.785), sepsis (1.603/1.132-2.270), and mortality was (2.298/1.629-3.242). The severe burn cohort had ORs and 95% CI for MI (3.145/1.469-6.732), sepsis (0.993/0.555-1.777), and mortality (2.934/1.924-4.475). In conclusion, the patients with earlier elevated cTnI levels had worse outcomes of MI and mortality in both severe and mild burns., (© The Author(s) 2024. Published by Oxford University Press on behalf of the American Burn Association. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
26. Equity in the Early Pain Management of Long Bone Fractures in Black vs White Patients: We Have Closed the Gap.
- Author
-
Jehle D, Paul KK, Troung S, Rogers JM, Mireles B, Straub JJ, Golovko G, Talbott MM, Lindsey RW, and Mouton CP
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Analgesics therapeutic use, Black or African American, Emergency Service, Hospital statistics & numerical data, Fractures, Bone, Retrospective Studies, United States epidemiology, White, Analgesics, Opioid therapeutic use, Femoral Fractures ethnology, Healthcare Disparities statistics & numerical data, Healthcare Disparities ethnology, Pain Management methods
- Abstract
Introduction: Patients with long bone fractures often present to the emergency department (ED) with severe pain and are typically treated with opioid and non-opioid analgesics. Historical data reveals racial disparities in analgesic administration, with White patients more likely to receive analgesics. With the diversifying US population, health equity is increasingly crucial. In this study we aimed to evaluate the early administration of opioid and non-opioid analgesia among Black and White patients with long bone and femur fractures in EDs over different time frames using a substantial database., Methods: We retrospectively extracted Information from 57 US healthcare organizations within the TriNetX database, encompassing 95 million patients. The ED records from 2003-2023 were subjected to propensity score matching for age and gender. We focused on four cohorts: two comprising Black and White patients diagnosed with long bone fractures, and another two with Black and White patients diagnosed solely with femur fractures. We examined analgesic administration rates over 20 years (2003-2023) at five-year intervals (2003-2008; 2008-2013; 2013-2018; 2018-2023), and further analyzed the rates for the most recent two-year period (2021-2023)., Results: Disparities in analgesic administration significantly diminished over the study period. For patients with long bone fractures (1,095,052), the opioid administration gap narrowed from 6.3% to 1.1%, while non-opioid administration disparities reduced from 4.4% to 0.3%. Similar trends were noted for femur fractures (265,181). By 2021-2023, no significant differences in analgesic administration were observed between racial groups., Conclusion: Over the past 20 years, the gap in early administration of opioid and non-opioid analgesics for Black and White patients presenting with long bone fractures or femur fractures has been disappearing., Competing Interests: Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1 TR001439) from the National Center for Advancing Translational Sciences, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. There are no other conflicts of interest or sources of funding to declare.
- Published
- 2024
- Full Text
- View/download PDF
27. Metformin is associated with reduced risk of mortality and morbidity in burn patients compared to insulin.
- Author
-
Hallman TG, Golovko G, Song J, Palackic A, Wolf SE, and El Ayadi A
- Subjects
- Humans, Male, Female, Retrospective Studies, Middle Aged, Adult, Aged, Hypoglycemia chemically induced, Hypoglycemia epidemiology, Acidosis, Lactic chemically induced, Acidosis, Lactic epidemiology, Propensity Score, Drug Therapy, Combination, Glycemic Control methods, Metformin therapeutic use, Burns mortality, Burns drug therapy, Burns complications, Hypoglycemic Agents therapeutic use, Insulin therapeutic use, Hyperglycemia drug therapy, Sepsis drug therapy, Sepsis mortality
- Abstract
Purpose: The standard of care for burned patients experiencing hyperglycemia associated with the hypermetabolic response is insulin therapy. Insulin treatment predisposes burn patients to hypoglycemia, which increases morbidity and mortality. Metformin has been suggested as an alternative to insulin therapy for glycemic control in burn patients given its safety profile, but further research is warranted. This study investigated whether metformin use in burn patients is associated with improved glycemic control and morbidity/mortality outcomes compared to insulin use alone., Materials and Methods: Using the TriNetX database, we conducted a retrospective study of burned patients who were administered insulin, metformin, or both within one week of injury. Demographic, comorbidity, and burn severity information were collected. Patients were categorized by treatment type, propensity score-matched, and compared for the following outcomes within 3 months: hyperglycemia, hypoglycemia, sepsis, lactic acidosis, and death. Statistical significance was set a priori at p ≤ 0.05., Results: The insulin cohort was at increased risk for all outcomes (all p < 0.0001) compared to the metformin cohort, and an increased risk for sepsis, lactic acidosis, and death (all p ≤ 0.0002) compared to the insulin/metformin combination cohort. When compared to the metformin cohort, the combination cohort was at increased risk for all outcomes (all p ≤ 0.0107) except death., Conclusions: Treatment with metformin after burn is associated with a reduced risk of morbidity and mortality compared to insulin. The combination of insulin and metformin is no more effective in reducing the risk of hyperglycemia and hypoglycemia than insulin alone but is less effective than metformin alone., Competing Interests: Declaration of Competing Interest The authors do not have any financial disclosures or other conflicts of interest to report other than that SEW is the editor of this journal., (Copyright © 2024 Elsevier Ltd and International Society of Burns Injuries. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. PGRMC2 and HLA-G regulate immune homeostasis in a microphysiological model of human maternal-fetal membrane interface.
- Author
-
Lintao RCV, Richardson LS, Kammala AK, Chapa J, Yunque-Yap DA, Khanipov K, Golovko G, Dalmacio LMM, and Menon R
- Subjects
- Female, Humans, Pregnancy, Chorion metabolism, Decidua metabolism, Decidua immunology, Extraembryonic Membranes metabolism, Membrane Proteins metabolism, Membrane Proteins genetics, Trophoblasts metabolism, Trophoblasts immunology, HLA-G Antigens genetics, HLA-G Antigens metabolism, Homeostasis, Receptors, Progesterone metabolism, Receptors, Progesterone genetics
- Abstract
Chorion trophoblasts (CTCs) and immune cell-enriched decidua (DECs) comprise the maternal-fetal membrane interface called the chorio-decidual interface (CDi) which constantly gets exposed to maternal stressors without leading to labor activation. This study explored how CTCs act as a barrier at CDi. The roles of human leukocyte antigen (HLA)-G and progesterone receptor membrane component 2 (PGRMC2) in mediating immune homeostasis were also investigated. The CDi was recreated in a two-chamber microfluidic device (CDi-on-chip) with an outer chamber of primary DECs and immune cell line-derived innate immune cells and an inner chamber of wild-type or PGRMC2 or HLA-G knockout immortalized CTCs. To mimic maternal insults, DECs were treated with lipopolysaccharide, poly(I:C), or oxidative stress inducer cigarette smoke extract. Expression levels of inflammation and immunity genes via targeted RNA sequencing, production of soluble mediators, and immune cell migration into CTCs were determined. In CDi-on-chip, decidua and immune cells became inflammatory in response to insults while CTCs were refractory, highlighting their barrier function. HLA-G and PGRMC2 are found to be vital to immune homeostasis at the CDi, with PGRMC2 serving as an upstream regulator of inflammation, HLA-G expression, and mesenchymal-epithelial transition, and HLA-G serving as a frontline immunomodulatory molecule, thus preventing fetal membrane compromise., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
29. A proactive/reactive mass screening approach with uncertain symptomatic cases.
- Author
-
Lin J, Aprahamian H, and Golovko G
- Subjects
- Humans, Pandemics, COVID-19 Testing methods, Uncertainty, Computational Biology methods, COVID-19 diagnosis, COVID-19 epidemiology, SARS-CoV-2, Mass Screening methods, Algorithms
- Abstract
We study the problem of mass screening of heterogeneous populations under limited testing budget. Mass screening is an essential tool that arises in various settings, e.g., the COVID-19 pandemic. The objective of mass screening is to classify the entire population as positive or negative for a disease as efficiently and accurately as possible. Under limited budget, testing facilities need to allocate a portion of the budget to target sub-populations (i.e., proactive screening) while reserving the remaining budget to screen for symptomatic cases (i.e., reactive screening). This paper addresses this decision problem by taking advantage of accessible population-level risk information to identify the optimal set of sub-populations for proactive/reactive screening. The framework also incorporates two widely used testing schemes: Individual and Dorfman group testing. By leveraging the special structure of the resulting bilinear optimization problem, we identify key structural properties, which in turn enable us to develop efficient solution schemes. Furthermore, we extend the model to accommodate customized testing schemes across different sub-populations and introduce a highly efficient heuristic solution algorithm for the generalized model. We conduct a comprehensive case study on COVID-19 in the US, utilizing geographically-based data. Numerical results demonstrate a significant improvement of up to 52% in total misclassifications compared to conventional screening strategies. In addition, our case study offers valuable managerial insights regarding the allocation of proactive/reactive measures and budget across diverse geographic regions., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Lin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
30. Calcitonin Gene-Related Peptide Inhibition and Development of Acne and Rosacea.
- Author
-
Thang CJ, Lai J, Garate D, Golovko G, Wilkerson MG, Loder EW, and Barbieri JS
- Subjects
- Humans, Female, Male, Adult, Rosacea drug therapy, Acne Vulgaris drug therapy, Calcitonin Gene-Related Peptide antagonists & inhibitors
- Published
- 2024
- Full Text
- View/download PDF
31. Benzoyl peroxide for acne treatment is not associated with an increased risk of malignancy: A retrospective cohort study.
- Author
-
Garate D, Thang CJ, Lai J, Golovko G, Wilkerson MG, and Barbieri JS
- Abstract
Competing Interests: Conflicts of interest Dr Barbieri has received consulting fees from Dexcel Pharma for work unrelated to the current submission. Authors Garate and Thang and Drs Lai, Golovko, and Wilkerson have no conflicts of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
32. Cancer incidence following bariatric surgery in renal transplant recipients: a retrospective multi-center analysis.
- Author
-
Dongur L, Samman Y, Golovko G, Botnar K, Kueht ML, Moffett J, and Samreen S
- Abstract
Background: Obesity, a known independent risk factor for developing malignancy. Additionally, renal transplant recipients (RTR) confer a 2- to 4-fold increased risk of overall malignancies with an excess absolute risk of .7% per year. While transplant recipients are at risk for obesity and malignancy, the effect of bariatric surgery (BS) in the posttransplantation setting is not well known., Objectives: Our study primarily evaluated the impact of BS on cancer incidence in RTR with severe obesity in the posttransplantation setting. Weight loss outcomes were analyzed secondarily., Setting: University Hospital., Methods: A retrospective study using TriNetX database was developed to analyze cancer outcomes in RTR with posttransplantation BS versus RTR without BS from 2000 to 2023. After the exclusion process and propensity matching, both cohorts consisted of 153 patients., Results: RTR-BS had a significantly lower incidence of overall cancer and transplant-related cancers (P < .05). No significant difference was identified in cutaneous, gastrointestinal, and reproductive cancers. Percent Excess Weight Loss (%EWL) was significantly lower in RTR-only cohort (11.4%) versus RTR-BS cohort (57.8%) at 5 years. Sleeve gastrectomy (SG) patients (73.19%) had significantly higher %EWL than Roux en-Y gastric bypass (RYGB) patients (49.33%) at 3 years. No difference in cancer incidence was noted between SG and RYGB patients., Conclusion: Postrenal transplantation BS had a diminishing effect on overall and transplant-related cancer incidence in RTR with severe obesity. Significant weight loss was also demonstrated with post-renal transplantation BS., (Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
33. Genital Burns Are Associated with Worse Psychosocial and Physical Outcomes.
- Author
-
Shah S, Golovko G, Karim A, Segura C, Song J, Haseem M, Wolf S, and El Ayadi A
- Abstract
Genital burns are unique and complex injuries that impact patients physically and emotionally. This study investigates the specific impact of genital burns on psychosocial and physical outcomes. A retrospective cohort study was conducted using the TriNetX database, encompassing over 117 million patients from U.S. healthcare institutions. Patients with genital burns were identified and categorized into sub-cohorts based on TBSA and burn degree. Propensity score matching and cohort balancing were performed based on age, gender, race, and ethnicity. Outcomes were analyzed both short-term (1 month) and long-term (5 years), focusing on psychiatric and physical aspects. This study identified 3,496 genital burn patients over a 15-year period. Analyses revealed that genital burns significantly increased short-term risk of death (RR: 2.8), anxiety (RR: 2.656), hospitalization (RR: 2.167), and any anxiety, PTSD, or depression (RR: 2.363), and long-term risk of death (RR: 1.658) and pruritus (RR: 1.58) (all p<0.05). Interestingly, genital burn patients showed a lower risk of chronic joint pain compared to other burn injuries (RR: 0.815) (p<0.05). These results occurred independently of the extent of TBSA. Genital burns have a distinctive impact on patients, leading to higher rates of certain psychiatric morbidities and physical complications. This study highlights the need for tailored care and consideration of the unique challenges faced by patients with genital burns, both in the immediate aftermath and in the long term. Understanding the specific impacts of genital burns is vital for healthcare practitioners to develop care strategies and better support for patients recovering from such injuries., (© The Author(s) 2024. Published by Oxford University Press on behalf of the American Burn Association. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
34. Bicarbonate and Serum Lab Markers as Predictors of Mortality in the Trauma Patient.
- Author
-
Talbott MM, Waguespack AN, Armstrong PA, Davis JW, Paul KK, Williams SM, Golovko G, Person J, and Jehle D
- Subjects
- Humans, Retrospective Studies, Female, Male, Propensity Score, Lactic Acid blood, United States epidemiology, Adult, Middle Aged, Predictive Value of Tests, Bicarbonates blood, Biomarkers blood, Wounds and Injuries mortality, Wounds and Injuries blood
- Abstract
Introduction: Severe trauma-induced blood loss can lead to metabolic acidosis, shock, and death. Identification of abnormalities in the bicarbonate and serum markers may be seen before frank changes in vital signs in the hemorrhaging trauma patient, allowing for earlier lifesaving interventions. In this study the author aimed to evaluate the usefulness of serum bicarbonate and other lab markers as predictors of mortality in trauma patients within 30 days after injury., Methods: This retrospective, propensity-matched cohort study used the TriNetX database, covering approximately 92 million patients from 55 healthcare organizations in the United States, including 3.8 million trauma patients in the last two decades. Trauma patients were included if they had lab measurements available the day of the event. The analysis focused on mortality within 30 days post-trauma in comparison to measured lab markers. Cohorts were formed based on ranges of bicarbonate, lactate, and base excess levels., Results: Before propensity score matching, a total of 1,275,363 trauma patients with same-day bicarbonate, lactate, or base excess labs were identified. A significant difference in mortality was found across various serum bicarbonate lab ranges compared to the standard range of 21-27 milliequivalents per liter (mEq/L), post-propensity score matching. The relative risk of death was 6.806 for bicarbonate ≤5 mEq/L; 8.651 for 6-10; 6.746 for 11-15; 2.822 for 16-20; and 1.015 for bicarbonate ≥28. Serum lactate also displayed significant mortality outcomes when compared to a normal level of ≤2 millimoles per liter. Base excess showed similar significant correlation at different values compared to a normal base excess of -2 to 2 mEq/L., Conclusion: This study, approximately 100 times larger than prior studies, associated lower bicarbonate levels with increased mortality in the trauma patient. While lactate and base excess offer prognostic value, lower bicarbonate values have a higher relative risk of death. The greater predictive value of bicarbonate and accessibility during resuscitations suggests that it may be the superior prognostic marker in trauma., Competing Interests: Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1 TR001439) from the National Center for Advancing Translational Sciences, National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. There are no other conflicts of interest or sources of funding to declare.
- Published
- 2024
- Full Text
- View/download PDF
35. Evaluation of Type I Interferon Treatment in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
- Author
-
Tat VY, Huang P, Khanipov K, Tat NY, Tseng CK, and Golovko G
- Abstract
Coronavirus disease 2019 (COVID-19) continues to cause morbidity and mortality worldwide; therefore, effective treatments remain crucial to controlling it. As interferon-alpha (IFN-α) and -beta (β) have been proposed as COVID-19 treatments, we sought to assess their effectiveness on respiratory, cardiovascular, neurological, and psychiatric signs and symptoms, as well as PASC and death, in hospitalized COVID-19 patients without multiple sclerosis (MS). Using a federated data research network (TriNetX), we performed a retrospective cohort study of hospitalized COVID-19 patients without MS who received IFN-α or -β treatment, comparing them to a similar cohort who did not receive treatment. Following propensity-score matched analyses, we demonstrate that hospitalized COVID-19 patients who were treated with IFN-α or -β had significantly higher odds of death. In contrast, there was no significant difference in any other outcomes between 1-30 days or 1 day to anytime afterward. Overall, hospitalized COVID-19 patients without MS who were treated with IFN-α or -β had similar short- and long-term sequelae (except for mortality) as those who did not receive treatment. The potential benefits of utilizing IFN-α or -β treatment as therapeutics remain to be realized, and our research highlights the need to explore repurposing drugs for COVID-19 using real-world evidence.
- Published
- 2024
- Full Text
- View/download PDF
36. Evaluating alopecia areata risk among patients with seasonal and food allergies: A multicenter cohort study.
- Author
-
Garate D, Thang CJ, Murphy TL, Sharma D, Golovko G, Wilkerson MG, Guttman-Yassky E, Gulati N, and Ungar B
- Published
- 2024
- Full Text
- View/download PDF
37. Correction: Risk of Suicide and Self-Harm Following Gender-Affirmation Surgery.
- Author
-
Straub JJ, Paul KK, Bothwell LG, Deshazo SJ, Golovko G, Miller MS, and Jehle DV
- Abstract
[This corrects the article DOI: 10.7759/cureus.57472.]., Competing Interests: No competing interests declared., (Copyright © 2024, Straub et al.)
- Published
- 2024
- Full Text
- View/download PDF
38. An optimization framework for large-scale screening under limited testing capacity with application to COVID-19.
- Author
-
Lin J, Aprahamian H, and Golovko G
- Subjects
- Humans, United States epidemiology, SARS-CoV-2, COVID-19 Testing methods, COVID-19 diagnosis, COVID-19 epidemiology, Mass Screening methods
- Abstract
We consider the problem of targeted mass screening of heterogeneous populations under limited testing capacity. Mass screening is an essential tool that arises in various settings, e.g., ensuring a safe supply of blood, reducing prevalence of sexually transmitted diseases, and mitigating the spread of infectious disease outbreaks. The goal of mass screening is to classify whole population groups as positive or negative for an infectious disease as efficiently and accurately as possible. Under limited testing capacity, it is not possible to screen the entire population and hence administrators must reserve testing and target those among the population that are most in need or most susceptible. This paper addresses this decision problem by taking advantage of accessible population-level risk information to identify the optimal set of sub-populations to target for screening. We conduct a comprehensive analysis that considers the two most commonly adopted schemes: Individual testing and Dorfman group testing. For both schemes, we formulate an optimization model that aims to minimize the number of misclassifications under a testing capacity constraint. By analyzing the formulations, we establish key structural properties which we use to construct efficient and accurate solution techniques. We conduct a case study on COVID-19 in the United States using geographic-based data. Our results reveal that the considered proactive targeted schemes outperform commonly adopted practices by substantially reducing misclassifications. Our case study provides important managerial insights with regards to optimal allocation of tests, testing designs, and protocols that dictate the optimality of schemes. Such insights can inform policy-makers with tailored and implementable data-driven recommendations., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
39. A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development risk.
- Author
-
Garate D, Thang CJ, Golovko G, Wilkerson MG, and Barbieri JS
- Subjects
- Humans, Female, Adult, Young Adult, Risk Factors, Tetracycline adverse effects, Tetracycline therapeutic use, Tetracycline administration & dosage, Cohort Studies, Middle Aged, Adolescent, Breast Neoplasms drug therapy, Breast Neoplasms epidemiology, Acne Vulgaris drug therapy, Spironolactone adverse effects, Spironolactone therapeutic use, Anti-Bacterial Agents adverse effects, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents administration & dosage
- Published
- 2024
- Full Text
- View/download PDF
40. Evaluation of the association between tetracycline-class antibiotic use in patients with acne and idiopathic intracranial hypertension risk: a population-level cohort study.
- Author
-
Thang CJ, Garate D, O'Leary S, Golovko G, Wilkerson MG, and Barbieri JS
- Subjects
- Humans, Female, Male, Adult, Young Adult, Adolescent, Cohort Studies, Risk Factors, Tetracyclines adverse effects, Tetracyclines administration & dosage, Acne Vulgaris drug therapy, Anti-Bacterial Agents adverse effects, Anti-Bacterial Agents administration & dosage, Pseudotumor Cerebri chemically induced, Pseudotumor Cerebri epidemiology
- Abstract
Competing Interests: Conflicts of interest J.S.B. has received consulting fees from Dexcel Pharma for work unrelated to the current submission. The other authors declare no conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
41. Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study.
- Author
-
Gosnell JM, Golovko G, Arroyave E, Moghe A, Kueht ML, Saldarriaga OA, McKinney KH, Stevenson HL, and Ferguson MR
- Abstract
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are a growing health burden across a significant portion of the global patient population. However, these conditions seem to have disparate rates and outcomes between different ethnic populations. The combination of MASLD/MASH and type 2 diabetes increases the risk of hepatocellular carcinoma (HCC), and Hispanic patients experience the greatest burden, particularly those in South Texas., Aim: To compare outcomes between Hispanic and non-Hispanic patients in the United States, while further focusing on the Hispanic population within Southeast Texas to determine whether the documented disparity in outcomes is a function of geographical circumstance or if there is a more widespread reason that all clinicians must account for in prognostic consideration., Methods: This cohort analysis was conducted with data obtained from TriNetX, LLC ("TriNetX"), a global federated health research network that provides access to deidentified medical records from healthcare organizations worldwide. Two cohort networks were used: University of Texas Medical Branch (UTMB) hospital and the United States national database collective to determine whether disparities were related to geographic regions, like Southeast Texas., Results: This study findings revealed Hispanics/Latinos have a statistically significant higher occurrence of HCC, type 2 diabetes mellitus, and liver fibrosis/cirrhosis in both the United States and the UTMB Hispanic/Latino groups. All-cause mortality in Hispanics/Latinos was lower within the United States group and not statistically elevated in the UTMB cohort., Conclusion: This would appear to support that Hispanic patients in Southeast Texas are not uniquely affected compared to the national Hispanic population., Competing Interests: Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article., (©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
42. Bidirectional association between alopecia areata and prurigo nodularis: a population-based cohort study using TriNetX.
- Author
-
Garate D, Thang CJ, Lai J, Hansen A, Golovko G, Wilkerson MG, and Barbieri JS
- Subjects
- Humans, Female, Male, Adult, Middle Aged, Cohort Studies, Young Adult, Aged, Adolescent, Alopecia Areata epidemiology, Alopecia Areata diagnosis, Alopecia Areata complications, Prurigo epidemiology, Prurigo diagnosis
- Published
- 2024
- Full Text
- View/download PDF
43. Support for Thrombolytic Therapy for Acute Stroke Patients on Direct Oral Anticoagulants: Mortality and Bleeding Complications.
- Author
-
Koscumb P, Murphy L, Talbott M, Nuti S, Golovko G, Shaltoni H, and Jehle D
- Subjects
- Humans, Retrospective Studies, Female, Male, Aged, United States epidemiology, Administration, Oral, Ischemic Stroke mortality, Ischemic Stroke drug therapy, Middle Aged, Intracranial Hemorrhages chemically induced, Intracranial Hemorrhages mortality, Stroke mortality, Stroke drug therapy, Aged, 80 and over, Blood Transfusion statistics & numerical data, Thrombolytic Therapy adverse effects, Tissue Plasminogen Activator therapeutic use, Fibrinolytic Agents therapeutic use, Fibrinolytic Agents adverse effects, Anticoagulants therapeutic use, Anticoagulants adverse effects, Propensity Score
- Abstract
Background: Alteplase (tPA) is the initial treatment for acute ischemic stroke. Current tPA guidelines exclude patients who took direct oral anticoagulants (DOAC) within the prior 48 hours. In this propensity-matched retrospective study we compared acute ischemic stroke patients treated with tPA who had received DOACs within 48 hours of thrombolysis to those not previously treated with DOACs, regarding three outcomes: mortality; intracranial hemorrhage (ICH); and need for acute blood transfusions (as a marker of significant blood loss)., Methods: Using the United States cohort of 54 healthcare organizations in the TriNetx database, we identified 8,582 stroke patients treated with tPA on DOACs within 48 hours of thrombolysis and 46,703 stroke patients treated with tPA not on DOACs since January 1, 2012. We performed propensity score matching on demographic information and seven prior clinical diagnostic groups, resulting in a total of 17,164 acute stroke patients evenly matched between groups. We recorded mortality rates, frequency of ICH, and need for blood transfusions for each group over the ensuing 7- and 30-day periods., Results: Patients treated with tPA on DOACs had reduced mortality (3.3% vs 7.3%; risk ratio [RR] 0.456; P < 0.001), fewer ICHs (6.8% vs 10.1%; RR 0.678; P < 0.001), and less risk of major bleeding as measured by frequency of blood transfusions (0.5% vs 1.5%; RR 0.317; p < 0.001) at 7 days post thrombolytic, than the tPA patients not on DOACS. Findings for 30 days post-thrombolytics were similar/statistically significant with lower mortality rate (7.2% vs 13.1%; RR 0.550; P < 0.001), fewer ICHs (7.6% vs 10.8%; RR 0.705; P < 0.001), and fewer blood transfusions (0.9% vs 2.0%; RR 0.448; P < 0.001)., Conclusion: Acute ischemic stroke patients treated with tPA who received DOACs within 48 hours of thrombolysis had lower mortality rates, reduced incidence of ICH, and less blood loss than those not on DOACs. Our study suggests that prior use of DOACs should not be a contraindication to thrombolysis for ischemic stroke., Competing Interests: Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. This research was supported by the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1 TR001439) from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. There are no conflicts of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
44. Risk of Suicide and Self-Harm Following Gender-Affirmation Surgery.
- Author
-
Straub JJ, Paul KK, Bothwell LG, Deshazo SJ, Golovko G, Miller MS, and Jehle DV
- Abstract
Introduction With the growing acceptance of transgender individuals, the number of gender affirmation surgeries has increased. Transgender individuals face elevated depression rates, leading to an increase in suicide ideation and attempts. This study evaluates the risk of suicide or self-harm associated with gender affirmation procedures. Methods This retrospective study utilized de-identified patient data from the TriNetX (TriNetX, LLC, Cambridge, MA) database, involving 56 United States healthcare organizations and over 90 million patients. The study involved four cohorts: cohort A, adults aged 18-60 who had gender-affirming surgery and an emergency visit (N = 1,501); cohort B, control group of adults with emergency visits but no gender-affirming surgery (N = 15,608,363); and cohort C, control group of adults with emergency visits, tubal ligation or vasectomy, but no gender-affirming surgery (N = 142,093). Propensity matching was applied to cohorts A and C. Data from February 4, 2003, to February 4, 2023, were analyzed to examine suicide attempts, death, self-harm, and post-traumatic stress disorder (PTSD) within five years of the index event. A secondary analysis involving a control group with pharyngitis, referred to as cohort D, was conducted to validate the results from cohort C. Results Individuals who underwent gender-affirming surgery had a 12.12-fold higher suicide attempt risk than those who did not (3.47% vs. 0.29%, RR 95% CI 9.20-15.96, p < 0.0001). Compared to the tubal ligation/vasectomy controls, the risk was 5.03-fold higher before propensity matching and remained significant at 4.71-fold after matching (3.50% vs. 0.74%, RR 95% CI 2.46-9.024, p < 0.0001) for the gender affirmation patients with similar results with the pharyngitis controls. Conclusion Gender-affirming surgery is significantly associated with elevated suicide attempt risks, underlining the necessity for comprehensive post-procedure psychiatric support., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, Straub et al.)
- Published
- 2024
- Full Text
- View/download PDF
45. Granuloma annulare is associated with an increased risk of hematologic malignancies: A multicenter cohort study using TriNetX.
- Author
-
Garate D, Thang CJ, Damsky W, Rosenbach M, Golovko G, Wilkerson MG, and Barbieri JS
- Subjects
- Humans, Cohort Studies, Granuloma Annulare complications, Granuloma Annulare epidemiology, Hematologic Neoplasms complications, Hematologic Neoplasms epidemiology
- Abstract
Competing Interests: Conflicts of interest Dr Barbieri has received consulting fees from Dexcel Pharma for work unrelated to the current submission. Authors Garate and Thang and Drs Damsky, Rosenabach, Golovko, and Wilkerson have no other conflicts to declare.
- Published
- 2024
- Full Text
- View/download PDF
46. Post-traumatic stress disorder in burn patients - A large database analysis.
- Author
-
Iglesias N, Campbell MS, Dabaghi E, Prasai A, Ben-Aissa A, Ozhathil D, Jay J, Song J, Golovko G, Wolf S, and El Ayadi A
- Subjects
- Humans, Incidence, Prevalence, Anxiety Disorders, Retrospective Studies, Burns complications, Burns epidemiology, Stress Disorders, Post-Traumatic epidemiology, Stress Disorders, Post-Traumatic etiology
- Abstract
Introduction: Post-traumatic stress disorder (PTSD) afflicts a significant portion of burn patients. This study aims to analyze the morbidity, prevalence, and treatment of PTSD in the burn population., Methods: Using the TriNetX database, we identified burned patients > 18 years of age without (A) or with (B) a PTSD diagnosis. Patients were then stratified by percent of total body surface area (TBSA) burned. Morbidity and mortality was analyzed in each cohort. Prevalence and pharmacologic treatments for PTSD were analyzed from 2002 to 2022., Results: PTSD incidence increased from 2.4% (n = 2281) in patients with < 10% to 3.1% (n = 542) in 10-30%, 7.4% (n = 285) in 30-59%, and 5.3% (n = 90) in > 60% TBSA burned. In patients with < 60% TBSA burned, PTSD diagnosis increased the risk of depression (p = <0.0003) and anxiety (p = <0.0001). In those with < 30% TBSA burned, PTSD diagnosis also increased risk of insomnia (p = <0.0001) and pruritus (p = 0.0211 for TBSA <10% and 0.0059 for TBSA 10-29%). PTSD diagnosis was associated with a decreased risk of mortality in patients with > 30% TBSA burned (p = 0.0179 for TBSA 30-59% and p = 0.0089 for TBSA >60%). From 2002 to 2022, the prevalence of PTSD in all burn patients was relatively stable between 2.2% and 3.2%. We found an increase in the use of serotonergic agents and prazosin for the treatment of PTSD during this timeframe., Conclusion: PTSD is not uncommon in the burn population, and those with burns and concomitant PTSD have an increased risk of morbidity. Screening and preventative measures to reduce morbidity and early implementation of care in burned patients with PTSD are indicated., Competing Interests: Declaration of Competing Interest The authors have no conflict of Interest to disclose., (Copyright © 2024 Elsevier Ltd and International Society of Burns Injuries. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
47. THE RISKS OF FIRST ONSET PRIMARY HYPERTENSION DIAGNOSIS IN THERMAL-INJURED PATIENTS.
- Author
-
Efejuku TA, Wolf SE, Song J, Golovko G, and El Ayadi A
- Subjects
- Female, Humans, Male, Essential Hypertension complications, Acute Kidney Injury diagnosis, Acute Kidney Injury etiology, Burns, Heart Failure, Hyperglycemia complications, Hypertension complications
- Abstract
Abstract: Introduction: Hypertension is a prevalent condition in the United States and leads to an increased risk of developing various comorbidities. However, the impact of new-onset hypertension after severe burns on patient outcomes is not known. We posit that hypertension onset after severe burn is associated with increased risk of developing comorbidities and mortality. Methods: Using the TriNetX database, burned patients diagnosed with essential hypertension after injury were compared with those who did not develop hypertension; neither had prior hypertension. Each cohort was grouped by sex, percent total body surface area (TBSA) burned, and age, then propensity matched for sex, race, ethnicity, and laboratory values. Outcomes assessed were acute kidney injury (AKI), hyperglycemia, heart failure, myocardial infarction (MI), and death. Results: Those diagnosed with hypertension after severe burn were 4.9 times more likely to develop AKI, 3.6 times for hyperglycemia, 5.3 times for heart failure, 4.7 times for acute MI, and 1.5 times for mortality. Sex analysis shows that men were at greater risk for AKI (1.5 times), heart failure (1.1 times), and death (1.4 times). Women were 1.3 times more likely to develop hyperglycemia. Percent TBSA burned grouping showed increased risk for all outcomes with increasing severity. Age grouping indicated an elevated risk of developing AKI, heart failure, acute MI, and death. Conclusion: New-onset hypertension diagnosis in severely burned patients is associated with acute kidney injury, heart failure, acute MI, and death. Overall, males, older patients, and those with a higher % TBSA burned are at a higher risk of developing these comorbidities., Competing Interests: The authors report no conflicts of interest., (Copyright © 2024 by the Shock Society.)
- Published
- 2024
- Full Text
- View/download PDF
48. Interkingdom interactions shape the fungal microbiome of mosquitoes.
- Author
-
Hegde S, Khanipov K, Hornett EA, Nilyanimit P, Pimenova M, Saldaña MA, de Bekker C, Golovko G, and Hughes GL
- Abstract
Background: The mosquito microbiome is an important modulator of vector competence and vectoral capacity. Unlike the extensively studied bacterial microbiome, fungal communities in the mosquito microbiome (the mycobiome) remain largely unexplored. To work towards getting an improved understanding of the fungi associated with mosquitoes, we sequenced the mycobiome of three field-collected and laboratory-reared mosquito species (Aedes albopictus, Aedes aegypti, and Culex quinquefasciatus)., Results: Our analysis showed both environment and host species were contributing to the diversity of the fungal microbiome of mosquitoes. When comparing species, Ae. albopictus possessed a higher number of diverse fungal taxa than Cx. quinquefasciatus, while strikingly less than 1% of reads from Ae. aegypti samples were fungal. Fungal reads from Ae. aegypti were < 1% even after inhibiting host amplification using a PNA blocker, indicating that this species lacked a significant fungal microbiome that was amplified using this sequencing approach. Using a mono-association mosquito infection model, we confirmed that mosquito-derived fungal isolates colonize Aedes mosquitoes and support growth and development at comparable rates to their bacterial counterparts. Strikingly, native bacterial taxa isolated from mosquitoes impeded the colonization of symbiotic fungi in Ae. aegypti suggesting interkingdom interactions shape fungal microbiome communities., Conclusion: Collectively, this study adds to our understanding of the fungal microbiome of different mosquito species, that these fungal microbes support growth and development, and highlights that microbial interactions underpin fungal colonization of these medically relevent species., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
49. The Utilisation of INR to identify coagulopathy in burn patients.
- Author
-
Wermine K, Song J, Gotewal S, Huang L, Corona K, Bagby S, Villarreal E, Chokshi S, Efejuku T, Chaij J, Joglar A, Iglesias NJ, Keys P, De La Tejera G, Golovko G, El Ayadi A, and Wolf SE
- Subjects
- Humans, Adult, Middle Aged, Aged, Aged, 80 and over, International Normalized Ratio, Prognosis, Blood Transfusion, Retrospective Studies, Burns, Blood Coagulation Disorders etiology
- Abstract
Studies conflict on the significance of burn-induced coagulopathy. We posit that burn-induced coagulopathy is associated with injury severity in burns. Our purpose was to characterize coagulopathy profiles in burns and determine relationships between % total burn surface area (TBSA) burned and coagulopathy using the International Normalized Ratio (INR). Burned patients with INR values were identified in the TriNetX database and analyzed by %TBSA burned. Patients with history of transfusions, chronic hepatic failure, and those on anticoagulant medications were excluded. Interquartile ranges for INR in the burned study population were 1.2 (1.0-1.4). An INR of ≥ 1.5 was used to represent those with burn-induced coagulopathy as it fell outside the 3rd quartile. The population was stratified into subgroups using INR levels <1.5 or ≥1.5 on the day of injury. Data are average ± SD analyzed using chi-square; p < .05 was considered significant. There were 7,364 burned patients identified with INR <1.5, and 635 had INR ≥1.5. Comparing TBSA burned groups, burn-induced coagulopathy significantly increased in those with ≥20% TBSA; p = .048 at 20-29% TBSA, p = .0005 at 30-39% TBSA, and p < .0001 for 40% TBSA and above. Age played a significant factor with average age for those with burn-induced coagulopathy 59 ± 21.5 years and 46 ± 21.8 for those without (p < .0001). After matching for age, TBSA, and demographics, the risk of 28 day-mortality was higher in those with burn-induced coagulopathy compared to those without (risk difference 20.9%, p < .0001) and the odd ratio with 95% CI is 4.45 (3.399-5.825). Investigation of conditions associated with burn-induced coagulopathy showed the effect of heart diseases to be significant; 53% of patients with burn-induced coagulopathy had hypertension (p < .0001). Burn-induced coagulopathy increases with %TBSA burned. The information gained firmly reflects a link between %TBSA and burn-induced coagulopathy, which could be useful in prognosis and treatment decisions., Competing Interests: No competing interests, (Copyright: © 2024 Wermine et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
50. Patterns of antibiotic administration in patients with burn injuries: A TriNetX study.
- Author
-
Wermine K, Gotewal S, Song J, Huang LG, Corona KK, Chokshi SN, Villarreal EL, Efejuku TA, Chaij JM, Bagby SP, Haseem M, Ko A, Keys PH, De La Tejera G, Peterson JM, Ozhathil DK, Golovko G, El Ayadi A, and Wolf SE
- Subjects
- Humans, United States, Aged, Infant, Anti-Bacterial Agents therapeutic use, Retrospective Studies, Burns drug therapy
- Abstract
Background: In the advent of increasing antibiotic resistance, several studies sought to determine antibiotic prescription trends; however, no pattern has been firmly identified particularly for the burned population. We performed a query of burned patients in a large established database to understand differences in antibiotic use related to patient-specific factors., Methods: Burned patients with systemic antibiotics given within 7 days of injury were identified on the TriNetX database. The patient population was stratified by age, 1-year time intervals of antibiotic prescription from 2004 to 2019, time of antibiotic prescription in 1-day intervals after injury, and % TBSA burned in 10% intervals ranging from < 10% to > 90%. Data were analyzed using χ
2 with p < 0.05 considered significant. Pearson coefficients (r2 ) values were used to correlate differences in antibiotic prescription between age groups and to changes over time., Results: Stratification by age revealed higher use of antibiotics in older burned patients compared to younger patients. Surprisingly, 87.6% of burn patients of those who received antibiotic therapy was on the day of injury. Penicillins and beta-lactam antimicrobials were used most often at a frequency of 64%. No statistically significant differences in rates of antibiotic therapy were observed in burned patients when stratified by %TBSA burned., Conclusions: The study elucidates current patterns of antibiotic use in burn care in the United States, allowing for improved understanding of both past and present patterns of antibiotic prescription., (Copyright © 2023 Elsevier Ltd and ISBI. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.